NIH-funded research R21 grant

How nerve signals affect the development of brain cells

Official title: Axonal signaling regulating oligodendrocyte differentiation

Funded at University of Colorado Denver · NIH-10986671 · Data updated 2026-11-12

This study is looking at how changes in nerve activity affect the growth of important brain cells that help with myelination, which is essential for healthy brain function, and it's being done in mice to better understand how these processes work during early brain development.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$444,599
NIH project number1R21NS135041-01A1
Project IDNIH-10986671 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions affecting myelination or brain development, particularly those with early developmental disorders.

Less likely to help

Patients with fully developed nervous systems or those not affected by myelination issues may not benefit from this research.

What this research studies

This research investigates how changes in nerve activity influence the development of oligodendrocyte progenitor cells, which are crucial for myelination in the brain. Using a specialized technique called DREADD, researchers will manipulate neuronal activity in mice to observe its effects on the growth and differentiation of these cells in the corpus callosum and cortex. By analyzing gene expression changes through advanced sequencing methods, the study aims to clarify the role of neuronal activity during early brain development and its impact on cell maturation.

Why it matters

Potential benefit: If successful, this research could lead to new insights into brain development and potential therapies for conditions related to myelination.

How similar studies have gone: While the approach of manipulating neuronal activity is established, the specific findings regarding premature differentiation in oligodendrocyte progenitor cells are novel and not extensively tested.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Macklin, Wendy B — University of Colorado Denver
  • Study coordinator: Macklin, Wendy B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.